PHILADELPHIA, PA – October 27, 2004 – LANNETT COMPANY, INC. (AMEX: LCI) is proud to announce the signing of an agreement with Orion Pharma (Orion), Finland’s leading drug company,...

PHILADELPHIA, PA – October 22, 2004 – LANNETT COMPANY, INC. (AMEX: LCI) is proud to announce the signing of an agreement with Orion Pharma (Orion), one of Finland’s leading drug...

PHILADELPHIA, PA – September 14, 2004 – LANNETT COMPANY, INC. (AMEX: LCInews) is pleased to announce the addition of Albert I. Wertheimer, PhD, MBA, to its Board of Directors. Dr....

PHILADELPHIA, PA – August 10, 2004 – LANNETT COMPANY, INC. (AMEX: LCI) releases a statement regarding events that have occurred during its fiscal year ended June 30, 2004. On February...

PHILADELPHIA, PA – May 5, 2004 – LANNETT® COMPANY, INC. (AMEX: LCI) announced that it has signed a contract with Jerome Stevens Pharmaceutical, Inc. (JSP), its primary supplier, for...

PHILADELPHIA, PA – March 29, 2004 – LANNETT® COMPANY, INC. (AMEX: LCI), today, has issued a statement to clarify matters, based upon shareholder inquiries regarding the potential...